MedImmune LLC:企業の戦略的SWOT分析

◆英語タイトル:MedImmune LLC - Strategic SWOT Analysis Review
◆商品コード:DATA904C15788
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MedImmune LLC – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture, and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibodies and other next-generation molecules targeting various diseases. MedImmune undertakes research in the areas of cancer treatment; respiratory; inflammation and autoimmune; and cardiovascular disorders and metabolic diseases. It also develops vaccines for the prevention of infectious diseases. The company operates three R&D centers in Gaithersburg, Maryland; Cambridge, the UK; and Mountain View, California. MedImmune is headquartered in Gaithersburg, Maryland, the US.

MedImmune LLC Key Recent Developments

Feb 14,2019 “MedImmune” brand to be retired as biologics integrate into AstraZeneca’s new R&D structure
Dec 04,2018 CELLINK announces collaboration with MedImmune to utilize CELLINKs’ 3D-Bioprinting technology for drug discovery
Sep 14,2018 US FDA Approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for Certain Patients with Relapsed or Refractory Hairy Cell Leukemia[Newswire : Healthcare-BW]
Aug 20,2018 AstraZeneca is advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018
Jun 18,2018 N4 Pharma: Update on Nuvec

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
MedImmune LLC – Key Facts
MedImmune LLC – Key Employees
MedImmune LLC – Key Employee Biographies
MedImmune LLC – Major Products and Services
MedImmune LLC – History
MedImmune LLC – Company Statement
MedImmune LLC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
MedImmune LLC – Business Description
MedImmune LLC – SWOT Analysis
SWOT Analysis – Overview
MedImmune LLC – Strengths
MedImmune LLC – Weaknesses
MedImmune LLC – Opportunities
MedImmune LLC – Threats
MedImmune LLC – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
MedImmune LLC, Recent Deals Summary
Section 4 – Company’s Recent Developments
Feb 14, 2019: “MedImmune” brand to be retired as biologics integrate into AstraZeneca’s new R&D structure
Dec 04, 2018: CELLINK announces collaboration with MedImmune to utilize CELLINKs’ 3D-Bioprinting technology for drug discovery
Sep 14, 2018: US FDA Approves LUMOXITI™ (moxetumomab pasudotox-tdfk) for Certain Patients with Relapsed or Refractory Hairy Cell Leukemia[Newswire : Healthcare-BW]
Aug 20, 2018: AstraZeneca is advancing understanding of cardio-renal-metabolic interconnectivity with new evidence at ESC 2018
Jun 18, 2018: N4 Pharma: Update on Nuvec
Apr 04, 2018: AstraZeneca’s early and late-stage oncology portfolio showcased at AACR annual meeting and ELCC
Feb 28, 2018: MedImmune to create stand-alone company for early-stage inflammation and autoimmunity biologics
Jan 01, 2018: New Bio-Incubator and Life-Science Accelerator Capability Launches at the Babraham Research Campus
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
MedImmune LLC, Key Facts
MedImmune LLC, Key Employees
MedImmune LLC, Key Employee Biographies
MedImmune LLC, Major Products and Services
MedImmune LLC, History
MedImmune LLC, Other Locations
MedImmune LLC, Subsidiaries
MedImmune LLC, Key Competitors
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
MedImmune LLC, Recent Deals Summary

List of Figures
MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
MedImmune LLC, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[MedImmune LLC:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ERHC Energy Inc. (ERHE):企業財務及び戦略的SWOT分析
    Summary ERHC Energy Inc. (ERHC Energy) is an oil and gas company that acquires, explores and develops oil and gas assets in Sub-Saharan Africa. The company possesses deep water oil and gas exploration and production interests in the Gulf of Guinea and onshore interests in Republic of Chad and Republ …
  • NK Minda Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NK Minda Group Mergers and Acqu …
  • Consort Medical plc (CSRT):医療機器:M&Aディール及び事業提携情報
    Summary Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostic …
  • Cara Therapeutics Inc (CARA):医療機器:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Topotarget A/S:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Topotarget A/S Mergers and Acqu …
  • Bank of Alexandria (S.A.E):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Bank of Alexandria (S.A.E)" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictl …
  • Elite Surgical Supplies (Pty) Ltd:製品パイプライン分析
    Summary Elite Surgical Supplies (Pty) Ltd (Elite Surgical) is a medical device company that manufactures and distributes surgical instruments. The company provides spinal, arthoplasty and consumable surgical instruments. Its spinal products include stand alone equipment, cervical cage, boiling VBR, …
  • Otras Producciones de Energia, S.L.:企業のM&A・提携動向(エネルギー分野)
    Summary Otras Producciones de Energia, S.L. (OPDE) is a renewable energy company that develops, funds, constructs photo-voltaic installations. The company operates assets of its own as a power generation company and 100 MW of PV installations from third parties. It offers services such as selecting …
  • Unipack, Inc.:企業の戦略・SWOT・財務分析
    SummaryUnipack, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Bilfinger SE:企業の戦略・SWOT・財務分析
    SummaryBilfinger SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Alkane Energy Plc:電力:M&Aディール及び事業提携情報
    Summary Alkane Energy Plc (Alkane Energy), a subsidiary of Basalt Infrastructure Partners LLP, is a diversified company. The company power from coal mine methane and natural gas facilities. It has natural gas, coal bed methane, coal mine methane and shale gas. Alkane Energy design, builds and operat …
  • Lea County Electric Cooperative Inc:企業の戦略的SWOT分析
    Lea County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Bollore SA (BOL):企業財務及び戦略的SWOT分析
    Summary Bollore SA (Bollore) is a provider of transportation and logistics, communication, and electricity storage solutions. The company through its businesses provides plastic films for capacitors, electric batteries and super capacitors; ultra-thin and resistant shrink-wrap packaging films and ot …
  • Edmond de Rothschild (Suisse) S.A.:企業の戦略・SWOT・財務情報
    Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond de Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Wireless Age Communications, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Wireless Age Communications, Lt …
  • SunOil Ltd. (SOD):企業概要、財務及び戦略的SWOT分析
    Summary SunOil Ltd. (SunOil) is an oil and gas company. The company operates in acquiring, drilling, exploring, developing, and evaluating oil and natural gas assets in the US and Canada. It has oil and gas properties in the States of Montana and Wyoming, the US. The company has acquired leasing exp …
  • Esperion Therapeutics, Inc. (ESPR)(製薬・医療分野):企業M&A動向
    Summary Esperion Therapeutics, Inc. (Esperion) is a biotechnology company. The company develops and commercializes oral, small molecule therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperion’s products include ETC-1002, ESP41 …
  • Philex Mining Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Philex Mining Corporation Merge …
  • Remedent, Inc. (REMI):企業概要、財務及び戦略的SWOT分析
    Summary Remedent, Inc. (Remedent) is a dental product manufacturer. The company develops and offers porcelain veneer, teeth whitening and sensitivity and oral hygiene products. Its products include GlamSmile Veneers, FirstFit, Remewhite Formulation, River 8 and SmileMe. Remedent’s GlamSmile Veneers …
  • Cantel Medical Corp. (CMD)-医療機器分野:企業M&A・提携分析
    Summary Cantel Medical Corp. (Cantel) is a manufacturer and distributor of infection prevention and control products and services to the healthcare market. The company’s product portfolio includes water purification equipment, sterilants, disinfectants and cleaners, specialized medical device reproc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆